Equity Profile

CORZ

Core Scientific, Inc.

Information TechnologyApplication Software$7.2B

Mar28Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Core Scientific, Inc. operates in the information technology sector, focusing on application software....

Key Metrics to Watch

Revenue Growth

This metric will indicate how well Core Scientific is expanding its business and capturing market share.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CORZ Q2-2026 Earnings Preview

Context

Company Snapshot

Core Scientific, Inc. operates in the information technology sector, focusing on application software. The company is significant in the growing fields of cloud computing and artificial intelligence, providing software solutions that help businesses optimize their operations and data management.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-2100.11%

Avg Stock Reaction

+3.57%

Last Quarter Recap

In the last quarter, Core Scientific reported an EPS of -$1.06, significantly missing expectations. The stock reacted positively the following day, gaining 11%.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of the earnings report, especially given the company's recent performance. There is uncertainty about whether Core Scientific can turn around its profitability.

Bull Case

If Core Scientific shows strong revenue growth and improves its EPS, it could signal a recovery and boost investor confidence.

Bear Case

On the other hand, if the company continues to report losses and fails to provide a clear path to profitability, the stock may face downward pressure.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for the upcoming quarter?

This figure will be crucial for assessing the company's ability to scale and attract new customers.

Will Core Scientific provide guidance on when it expects to achieve profitability?

Clear guidance on profitability timelines will be critical for investor confidence and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Core Scientific's potential for a turnaround based on recent customer acquisition trends.

Supporting Evidence

Despite recent losses, the company has shown a consistent ability to surprise on the upside in previous quarters.

The options market indicates a higher expected move than historical averages, suggesting traders anticipate significant news.

The stock's recent performance indicates a potential for recovery that may not be fully reflected in current analyst expectations.

Key Risk

If revenue growth exceeds 15%, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether Core Scientific can shift its trajectory towards profitability.

Bull Confirmed If

Revenue growth of 20% or more compared to the previous quarter would confirm the bull case.

Bear Confirmed If

If the EPS remains below -$1.00, it would reinforce the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.47%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a potential move of about 5.5%, indicating that traders expect some volatility around the earnings announcement.

Options are pricing ±5.5% while CORZ has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

62.2%

Calls (8.5M)P/C Ratio: 0.20Puts (1.3M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Core Scientific beats expectations and raises guidance, history suggests the stock could rise by around 0.92% on the first day.

In-Line / Cautious

If results are in line but management expresses caution, the stock may experience a muted reaction.

Miss

If the company misses expectations, history suggests a potential decline of about 6.21% on the first day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on customer acquisition strategies and their effectiveness.
2Details on cost management efforts and their impact on profitability.
3Insights into market trends that could affect future growth.
4Management's outlook on competitive pressures in the application software space.
5Any commentary on potential partnerships or collaborations that could enhance growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

BioNTech SE

Company Snapshot

Core Scientific, Inc. operates in the information technology sector, focusing on application software....

Key Metrics to Watch

Revenue Growth

This metric will indicate how well Core Scientific is expanding its business and capturing market share.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CORZ Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-2100.11%

Avg Stock Reaction

+3.57%

Last Quarter Recap

In the last quarter, Core Scientific reported an EPS of -$1.06, significantly missing expectations. The stock reacted positively the following day, gaining 11%.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of the earnings report, especially given the company's recent performance. There is uncertainty about whether Core Scientific can turn around its profitability.

Bull Case

If Core Scientific shows strong revenue growth and improves its EPS, it could signal a recovery and boost investor confidence.

Bear Case

On the other hand, if the company continues to report losses and fails to provide a clear path to profitability, the stock may face downward pressure.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for the upcoming quarter?

This figure will be crucial for assessing the company's ability to scale and attract new customers.

Will Core Scientific provide guidance on when it expects to achieve profitability?

Clear guidance on profitability timelines will be critical for investor confidence and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Core Scientific's potential for a turnaround based on recent customer acquisition trends.

Supporting Evidence

Despite recent losses, the company has shown a consistent ability to surprise on the upside in previous quarters.

The options market indicates a higher expected move than historical averages, suggesting traders anticipate significant news.

The stock's recent performance indicates a potential for recovery that may not be fully reflected in current analyst expectations.

Key Risk

If revenue growth exceeds 15%, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether Core Scientific can shift its trajectory towards profitability.

Bull Confirmed If

Revenue growth of 20% or more compared to the previous quarter would confirm the bull case.

Bear Confirmed If

If the EPS remains below -$1.00, it would reinforce the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.47%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a potential move of about 5.5%, indicating that traders expect some volatility around the earnings announcement.

Options are pricing ±5.5% while CORZ has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

62.2%

Calls (8.5M)P/C Ratio: 0.20Puts (1.3M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Core Scientific beats expectations and raises guidance, history suggests the stock could rise by around 0.92% on the first day.

In-Line / Cautious

If results are in line but management expresses caution, the stock may experience a muted reaction.

Miss

If the company misses expectations, history suggests a potential decline of about 6.21% on the first day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on customer acquisition strategies and their effectiveness.
2Details on cost management efforts and their impact on profitability.
3Insights into market trends that could affect future growth.
4Management's outlook on competitive pressures in the application software space.
5Any commentary on potential partnerships or collaborations that could enhance growth.